Female-specific pruritus from childhood to postmenopause: Clinical features, hormonal factors, and treatment considerations

Lauren P. Rimoin, Shawn G. Kwatra, Gil Yosipovitch

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

There have been considerable advances in our understanding of the pathophysiology of pruritus in recent years. The purpose of this review was to highlight itch entities in women, and in particular pruritic vulvar dermatoses that women experience among different age groups. Unique temporal shifts may contribute to the etiology of many of these conditions. These changes lead to cyclical changes in the skin's basic composition. Specifically, estrogen receptors have been detected on keratinocytes that respond to rising and falling levels of estrogen. These receptors lead to changes in skin hydration, collagen content, and in the concentration of glycosaminoglycans that form the skin barrier. In addition, hormonal pH changes associated with the menstrual cycle may be an important factor in the aggravation of itch as increasing pH is known to activate the proteinase-activated receptor-2, a well-known itch mediator. Common pruritic conditions in women that will be discussed include atopic and irritant dermatitis, psoriasis, lichen sclerosus, infectious vulvovaginitis, vulvovaginal candidiasis, atrophic vulvovaginitis, squamous cell carcinoma, lichen simplex chronicus, and neuropathic itch. We also examine pruritic conditions associated with pregnancy including pemphigoid gestationis, polymorphic eruption of pregnancy, intrahepatic cholestasis of pregnancy and atopic eruption of pregnancy. Finally, acceptable and contraindicated antipruritic agents in pregnancy are examined.

Original languageEnglish (US)
Pages (from-to)157-167
Number of pages11
JournalDermatologic Therapy
Volume26
Issue number2
DOIs
StatePublished - Mar 1 2013
Externally publishedYes

Fingerprint

Postmenopause
Pruritus
Vulvovaginitis
Pregnancy
Skin
Antipruritics
Pemphigoid Gestationis
Vulvovaginal Candidiasis
Neurodermatitis
PAR-2 Receptor
Irritant Dermatitis
Lichen Sclerosus et Atrophicus
Atopic Dermatitis
Menstrual Cycle
Glycosaminoglycans
Keratinocytes
Psoriasis
Skin Diseases
Estrogen Receptors
Squamous Cell Carcinoma

Keywords

  • female itch
  • itch
  • pruritus
  • vulvovaginal itch

ASJC Scopus subject areas

  • Dermatology

Cite this

Female-specific pruritus from childhood to postmenopause : Clinical features, hormonal factors, and treatment considerations. / Rimoin, Lauren P.; Kwatra, Shawn G.; Yosipovitch, Gil.

In: Dermatologic Therapy, Vol. 26, No. 2, 01.03.2013, p. 157-167.

Research output: Contribution to journalArticle

@article{f400346664554ec2a3ba566e7ef8f62c,
title = "Female-specific pruritus from childhood to postmenopause: Clinical features, hormonal factors, and treatment considerations",
abstract = "There have been considerable advances in our understanding of the pathophysiology of pruritus in recent years. The purpose of this review was to highlight itch entities in women, and in particular pruritic vulvar dermatoses that women experience among different age groups. Unique temporal shifts may contribute to the etiology of many of these conditions. These changes lead to cyclical changes in the skin's basic composition. Specifically, estrogen receptors have been detected on keratinocytes that respond to rising and falling levels of estrogen. These receptors lead to changes in skin hydration, collagen content, and in the concentration of glycosaminoglycans that form the skin barrier. In addition, hormonal pH changes associated with the menstrual cycle may be an important factor in the aggravation of itch as increasing pH is known to activate the proteinase-activated receptor-2, a well-known itch mediator. Common pruritic conditions in women that will be discussed include atopic and irritant dermatitis, psoriasis, lichen sclerosus, infectious vulvovaginitis, vulvovaginal candidiasis, atrophic vulvovaginitis, squamous cell carcinoma, lichen simplex chronicus, and neuropathic itch. We also examine pruritic conditions associated with pregnancy including pemphigoid gestationis, polymorphic eruption of pregnancy, intrahepatic cholestasis of pregnancy and atopic eruption of pregnancy. Finally, acceptable and contraindicated antipruritic agents in pregnancy are examined.",
keywords = "female itch, itch, pruritus, vulvovaginal itch",
author = "Rimoin, {Lauren P.} and Kwatra, {Shawn G.} and Gil Yosipovitch",
year = "2013",
month = "3",
day = "1",
doi = "10.1111/dth.12034",
language = "English (US)",
volume = "26",
pages = "157--167",
journal = "Dermatologic Therapy",
issn = "1396-0296",
publisher = "Wiley-Blackwell",
number = "2",

}

TY - JOUR

T1 - Female-specific pruritus from childhood to postmenopause

T2 - Clinical features, hormonal factors, and treatment considerations

AU - Rimoin, Lauren P.

AU - Kwatra, Shawn G.

AU - Yosipovitch, Gil

PY - 2013/3/1

Y1 - 2013/3/1

N2 - There have been considerable advances in our understanding of the pathophysiology of pruritus in recent years. The purpose of this review was to highlight itch entities in women, and in particular pruritic vulvar dermatoses that women experience among different age groups. Unique temporal shifts may contribute to the etiology of many of these conditions. These changes lead to cyclical changes in the skin's basic composition. Specifically, estrogen receptors have been detected on keratinocytes that respond to rising and falling levels of estrogen. These receptors lead to changes in skin hydration, collagen content, and in the concentration of glycosaminoglycans that form the skin barrier. In addition, hormonal pH changes associated with the menstrual cycle may be an important factor in the aggravation of itch as increasing pH is known to activate the proteinase-activated receptor-2, a well-known itch mediator. Common pruritic conditions in women that will be discussed include atopic and irritant dermatitis, psoriasis, lichen sclerosus, infectious vulvovaginitis, vulvovaginal candidiasis, atrophic vulvovaginitis, squamous cell carcinoma, lichen simplex chronicus, and neuropathic itch. We also examine pruritic conditions associated with pregnancy including pemphigoid gestationis, polymorphic eruption of pregnancy, intrahepatic cholestasis of pregnancy and atopic eruption of pregnancy. Finally, acceptable and contraindicated antipruritic agents in pregnancy are examined.

AB - There have been considerable advances in our understanding of the pathophysiology of pruritus in recent years. The purpose of this review was to highlight itch entities in women, and in particular pruritic vulvar dermatoses that women experience among different age groups. Unique temporal shifts may contribute to the etiology of many of these conditions. These changes lead to cyclical changes in the skin's basic composition. Specifically, estrogen receptors have been detected on keratinocytes that respond to rising and falling levels of estrogen. These receptors lead to changes in skin hydration, collagen content, and in the concentration of glycosaminoglycans that form the skin barrier. In addition, hormonal pH changes associated with the menstrual cycle may be an important factor in the aggravation of itch as increasing pH is known to activate the proteinase-activated receptor-2, a well-known itch mediator. Common pruritic conditions in women that will be discussed include atopic and irritant dermatitis, psoriasis, lichen sclerosus, infectious vulvovaginitis, vulvovaginal candidiasis, atrophic vulvovaginitis, squamous cell carcinoma, lichen simplex chronicus, and neuropathic itch. We also examine pruritic conditions associated with pregnancy including pemphigoid gestationis, polymorphic eruption of pregnancy, intrahepatic cholestasis of pregnancy and atopic eruption of pregnancy. Finally, acceptable and contraindicated antipruritic agents in pregnancy are examined.

KW - female itch

KW - itch

KW - pruritus

KW - vulvovaginal itch

UR - http://www.scopus.com/inward/record.url?scp=84875850328&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84875850328&partnerID=8YFLogxK

U2 - 10.1111/dth.12034

DO - 10.1111/dth.12034

M3 - Article

C2 - 23551372

AN - SCOPUS:84875850328

VL - 26

SP - 157

EP - 167

JO - Dermatologic Therapy

JF - Dermatologic Therapy

SN - 1396-0296

IS - 2

ER -